Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.
2.

Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.

Pande M, Amos CI, Osterwisch DR, Chen J, Lynch PM, Broaddus R, Frazier ML.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2393-401. doi: 10.1158/1055-9965.EPI-08-0326.

3.

Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non smokers in lung cancer.

Ihsan R, Chauhan PS, Mishra AK, Yadav DS, Kaushal M, Sharma JD, Zomawia E, Verma Y, Kapur S, Saxena S.

PLoS One. 2011;6(12):e29431. doi: 10.1371/journal.pone.0029431.

4.

Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk.

Cleary SP, Cotterchio M, Shi E, Gallinger S, Harper P.

Am J Epidemiol. 2010 Nov 1;172(9):1000-14. doi: 10.1093/aje/kwq245.

5.

Microsomal epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.

Nisa H, Budhathoki S, Morita M, Toyomura K, Nagano J, Ohnaka K, Kono S, Ueki T, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Terasaka R.

Mol Carcinog. 2013 Aug;52(8):619-26. doi: 10.1002/mc.21897.

PMID:
22415791
6.

Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.

Rotunno M, Yu K, Lubin JH, Consonni D, Pesatori AC, Goldstein AM, Goldin LR, Wacholder S, Welch R, Burdette L, Chanock SJ, Bertazzi PA, Tucker MA, Caporaso NE, Chatterjee N, Bergen AW, Landi MT.

PLoS One. 2009 May 21;4(5):e5652. doi: 10.1371/journal.pone.0005652.

7.

CYP1A1, GSTM1, GSTT1 and NQO1 polymorphisms and colorectal adenomas in Japanese men.

Hamachi T, Tajima O, Uezono K, Tabata S, Abe H, Ohnaka K, Kono S.

World J Gastroenterol. 2013 Jul 7;19(25):4023-30. doi: 10.3748/wjg.v19.i25.4023.

8.

Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.

Nisa H, Kono S, Yin G, Toyomura K, Nagano J, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Terasaka R.

BMC Cancer. 2010 Jun 10;10:274. doi: 10.1186/1471-2407-10-274.

9.

CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer.

Boccia S, Cadoni G, Sayed-Tabatabaei FA, Volante M, Arzani D, De Lauretis A, Cattel C, Almadori G, van Duijn CM, Paludetti G, Ricciardi G.

J Cancer Res Clin Oncol. 2008 Jan;134(1):93-100.

PMID:
17611777
10.

Investigation of a possible relationship between EPHX1 gene polymorphisms and colorectal cancer in Turkish society.

Sahin O, Arikan S, Oltulu YM, Coskunpinar E, Eren A, Cacina C, Guler E, Yaylim I.

Genet Test Mol Biomarkers. 2012 May;16(5):423-8. doi: 10.1089/gtmb.2011.0223.

PMID:
22352736
11.

[Association analysis of polymorphisms of metabolizing enzyme genes with chronic benzene poisoning based on logistic regression and multifactor dimensionality reduction].

Jin RF, Wan JX, Gu SY, Sun P, Zhang ZB, Jin XP, Xia ZL.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2011 Jul;29(7):481-6. Chinese.

PMID:
22214149
12.

Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study.

Mitrou PN, Watson MA, Loktionov AS, Cardwell C, Gunter MJ, Atkin WS, Macklin CP, Cecil T, Bishop DT, Primrose J, Bingham SA.

Carcinogenesis. 2007 Apr;28(4):875-82.

PMID:
17082176
13.

Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

Goode EL, White KL, Vierkant RA, Phelan CM, Cunningham JM, Schildkraut JM, Berchuck A, Larson MC, Fridley BL, Olson JE, Webb PM, Chen X, Beesley J, Chenevix-Trench G, Sellers TA; Ovarian Cancer Association Consortium.; Australian Ovarian Cancer Study Group..

Mol Carcinog. 2011 May;50(5):397-402. doi: 10.1002/mc.20714.

14.

Passive smoking, metabolic gene polymorphisms, and infant birth weight in a prospective cohort study of Chinese women.

Wu T, Hu Y, Chen C, Yang F, Li Z, Fang Z, Wang L, Chen D.

Am J Epidemiol. 2007 Aug 1;166(3):313-22.

PMID:
17526865
15.

Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer.

Fan C, Jin M, Chen K, Zhang Y, Zhang S, Liu B.

BMC Cancer. 2007 Jun 30;7:115.

16.

Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.

Liu F, Yuan D, Wei Y, Wang W, Yan L, Wen T, Xu M, Yang J, Li B.

PLoS One. 2012;7(8):e43821. doi: 10.1371/journal.pone.0043821. Review.

17.

Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk.

Northwood EL, Elliott F, Forman D, Barrett JH, Wilkie MJ, Carey FA, Steele RJ, Wolf R, Bishop T, Smith G.

Pharmacogenet Genomics. 2010 May;20(5):315-26. doi: 10.1097/FPC.0b013e3283395c6a.

PMID:
20375710
18.

Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer.

Jain M, Tilak AR, Upadhyay R, Kumar A, Mittal B.

Toxicol Appl Pharmacol. 2008 Jul 15;230(2):247-51. doi: 10.1016/j.taap.2008.02.023.

PMID:
18406439
19.

Putative EPHX1 enzyme activity is related with risk of lung and upper aerodigestive tract cancers: a comprehensive meta-analysis.

Li X, Hu Z, Qu X, Zhu J, Li L, Ring BZ, Su L.

PLoS One. 2011 Mar 18;6(3):e14749. doi: 10.1371/journal.pone.0014749.

20.

Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population.

Sivonova MK, Dobrota D, Matakova T, Dusenka R, Grobarcikova S, Habala V, Salagovic J, Tajtakova M, Pidanicova A, Valansky L, Lachvacs L, Kliment J Jr, Nagy V, Kliment J.

Neoplasma. 2012;59(1):79-84.

PMID:
22103900

Supplemental Content

Support Center